SpikImm
- Biotech or pharma, therapeutic R&D
SpkImm is a partnership between Institut Pastteur & Truffle Capital focussed on delivering long acting passive immunity for immunocompromised patients. From initial work on Covid 19 MaBs , the compamy is now focussed on preve ting other viral infections in immunocompromised patients. The lead asset is against BKV in Renal Transplant, and against JCV which causes PML in at risk patients with near 100% mortality .
Address
ParisIle de France
France
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}